Acquisition in China Unither Pharmaceuticals initiated the acquisition of Nanjing Ruinian Best Pharmaceutical Co. Ltd., a Chinese pharmaceutical company.
CDMO’s Challenges for Developing Oral Suspensions for Children The American Pharmaceutical Review released a whitepaper in collaboration with Unither Pharmaceuticals on the CDMO’s Challenges for Developing Oral Suspensions for Children Since the... View Article
Using Differentiated Drug-Delivery Technologies to Deliver Competitive Advantages Using Differentiated Drug-Delivery Technologies to Deliver Competitive Advantages Novel drug delivery technologies enable manufacturers of all types to gain... View Article
Sol-Gel technology Unither supports innovation that will benefit patients. It is in this perspective that we have been collaborating with CNRS, Paris... View Article
A new safer, more practical and trendy packaging: the liquid stick-pack A new trendier display for the liquid medicines The food industry was the first to use stick-packs for condiments such... View Article
Sterile single doses: Blow-Fill-Seal (BFS), an ophthalmic technology Modern packaging guarantees the absence of preservatives Eye drops and gels for ophthalmic use in the form of sterile single-dose... View Article
Sterile single dose and limitation of contamination risks Packaged in a sterile environment without preservatives, sterile single-dose formulation avoids microbial contamination and meets the current needs of patients... View Article
Galenic innovations and roads of the future Galenic innovation : an interdisciplinary science in constant evolution Far from being an isolated science, “galenic innovation requires multiple interactions... View Article
Galenic innovations to meet the challenges of the future (Part 2) Biotechnology and nanomedicines: a potential with multiple aspects. When we talk about galenic innovation, we think today of the use... View Article
